secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2021-07-28T23:59:59+00:00
Accession:  0001005286-21-000040
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Landec reports Q4 net loss of $2.9M; Lifecore FY revenue up 14%; provides FY2022 guidance
--------------------------------------------------------------------------------

- Q4 revenue $139.8M (-10% YoY), net loss $2.9M vs loss $15.1M last year, adjusted EPS $0.07.
- FY2021 revenue $544.2M (-8% YoY), net loss $32.7M, adjusted EBITDA $31.4M (+43% YoY).
- Lifecore FY revenue $98.1M (+14%), EBITDA $24.5M (+22%); Curation Foods Q4 gross margin 11.9% (target 11-14%).
- FY2022 guidance: revenue $545-554M, adjusted EBITDA $33.3-35.5M; Lifecore revenue expected $105-108M.
- Director Patrick Walsh resigned July 27, not due to any disagreement; board reduced to 10 members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528621000040/0001005286-21-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528621000040/lndc-20210727.htm
  HTML page:      https://secwatch.observer/filing/0001005286-21-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer